South Korea-based startup AIRS Medical has announced a strategic growth investment from TA Associates, a leading global private equity firm. The investment will help fuel AIRS Medical’s next phase of global expansion, advancement of its AI-powered radiology technology solutions and ongoing product innovation..

韩国初创企业AIRS Medical宣布获得全球领先私募股权公司TA Associates的战略增长投资。这笔投资将助力AIRS Medical推进下一阶段的全球扩张，加速其人工智能放射技术解决方案的发展，并持续推动产品创新。

Founded in 2018, AIRS Medical develops AI-native magnetic resonance imaging (MRI) acceleration and reconstruction software designed to support MRI speed, image quality and workflow performance. Healthcare organisations and leading academic institutions are adopting AIRS Medical's technologies to expand imaging capacity and improve patient access..

AIRS Medical 成立于2018年，致力于开发原生于人工智能的磁共振成像（MRI）加速与重建软件，旨在提升MRI扫描速度、图像质量和工作流性能。医疗保健机构和领先学术机构正纷纷采用AIRS Medical的技术，以扩大影像检查容量并改善患者就医可及性。

Today, the company supports more than 1,700 healthcare institutions across over 40 countries, with its AI technologies utilised in more than 6 million MRI examinations annually.

如今，该公司为全球40多个国家的1,700多家医疗机构提供支持，其人工智能技术每年应用于超过600万次磁共振成像（MRI）检查。

As healthcare providers increasingly look to improve imaging efficiency by optimising existing infrastructure, AIRS Medical is uniquely positioned at the intersection of AI, medical imaging and healthcare operations to support their efforts. The company’s AI-powered MRI acceleration and image enhancement solution (SwiftMR.

随着医疗保健提供者日益希望通过优化现有基础设施来提高影像检查效率，AIRS Medical 凭借其在人工智能、医学影像和医疗运营交汇处的独特地位，为这些努力提供支持。该公司推出的基于人工智能的 MRI 加速与图像增强解决方案（SwiftMR

®

®

), and an MRI quantification and structured reporting platform (SwiftSight

），以及一个MRI量化和结构化报告平台（SwiftSight

®

®

), offer healthcare organisations a unified solution from image acquisition through clinical interpretation.

），为医疗机构提供从图像采集到临床解读的统一解决方案。